Category Archives: 2015

Food for Thought; Our Help in Weakness.

When we as individuals put our faith in Jesus Christ’s sacrifice for the payment of our sin debt to God, and asked Him to come into our lives, we received a special gift, namely the presence of the Holy Spirit more »

Posted in 2015 | Leave a comment

Don’t Let Yourself Go! The Benefits of Exercise During Hormone Therapy

A recent article written by researchers from the University of Southern California was published in the August 2015 issue of Prostate Insights from the Prostate Cancer Research Institute.  The article discussed how exercise may help with treatment-related side effects of more »

Posted in 2015 | Leave a comment

AR-V7: A Genetic Test to Determine Effectiveness of Enzalutamide and Abiraterone.

When prostate cancer becomes “hormone resistant” or refractory, anti-androgen drugs such as enzalutamide (Xtandi®) and abiraterone (Zytiga®) are often prescribed.  But not all patients respond equally. Some 30 percent of men with advanced prostate cancer have an abnormal version of more »

Posted in 2015 | Leave a comment

Don’t Miss a New Blog Post; Sign Up for Automatic Email Delivery.

While not every blog may be applicable to your specific condition and interest, you can get them delivered automatically to your e mail address.  Just go to the lower right hand corner of the Godandprostate home page and enter your more »

Posted in 2015 | Leave a comment

Taking Charge of Your Prostate Cancer Recovery; Old Model Revised.

The following is from the October 7th Prostatesnatchers, as written by Ralph Blum and urinary oncologist, Dr. Mark Scholz.  I urge the readers to subscribe to their periodic e mail posts. In the old model of prostate cancer care, you more »

Posted in 2015 | Leave a comment

Earlier chemotherapy may extend patient survival in multiple prostate cancer settings

Whether a prostate cancer patient is just presenting with localized high risk prostate cancer, presenting with metastatic prostate cancer, or experiencing a metastatic recurrence, earlier treatment with taxane chemotherapy may prolong survival. June 19, 2015 — Chemotherapy with docetaxel® (taxotere) more »

Posted in 2015 | Leave a comment

Men With Low-Risk Prostate Cancer In Active Surveillance Program Not Likely To Succomb To The Disease, Study Shows.

The post below comes from a multi-year study at Johns Hopkins in Baltimore. It should be noted below that repeat biopsies performed on men undergoing active surveillance were performed using MRI-guided technology and pathologists checked biopsy tissue levels of proteins more »

Posted in 2015 | Leave a comment

More Evidence for the Positive Effect of Statins and Metformin in High-Risk Prostate Cancer.

A total of 22,110 high-risk prostate cancer patients were evaluated of which 1,365 died of prostate cancer.  The study authors concluded that the use of a statin medication in combination with metformin was associated with a 43% reduction in prostate more »

Posted in 2015 | Leave a comment

Stereotactic Body Radiation (SBRT) and CyberKnife in the Treatment of Prostate Cancer

Stereotactic Body Radiation (SBRT) accurately delivers very high doses of external radiation beams to the whole prostate gland thereby treating the tumor within while minimizing extra-prostactic radiation exposure to the adjacent normal tissues.  Because SBRT delivers a much higher dose more »

Posted in 2015 | Leave a comment

Radiation Cystitis – An Undesirable Potential Side Effect of Radiation Therapy

I was recently made aware of an unexpected, undesirable side effect of prostate cancer radiation therapy called radiation cystitis which first occurred more than ten years after radiation treatment.  This can be caused by the incidental irradiation of the bladder more »

Posted in 2015 | Leave a comment